|
Sign In to gain access to subscriptions and/or personal tools.
|
Mutation and Overexpression of the Transgene in Ethylnitrosourea-Induced Tumors in Mice Carrying a Human Prototype c-Ha-ras Gene
Kaoru Toyosawa
Safety Research Laboratories, Dainippon Pharmaceutical Co, Ltd, Osaka 564-0053, Japan, kaoru-toyozawa{at}dainippon-pharm.co.jp
Kohji Tanaka
Safety Research Laboratories, Dainippon Pharmaceutical Co, Ltd, Osaka 564-0053, Japan
Toshio Imai
Division of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan
Kazuo Yasuhara
Division of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan
Takatoshi Koujitani
Safety Research Laboratories, Dainippon Pharmaceutical Co, Ltd, Osaka 564-0053, Japan, Division of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan
Masao Hirose
Division of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan
Kunitoshi Mitsumori
Division of Pathology, National Institute of Health Sciences, Tokyo 158-8501, Japan, Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, Tokyo 183-8509, Japan
To investigate mechanisms underlying accelerated carcinogenesis in mice carrying a human prototype c-Ha- ras gene (rasH2 mouse), mutations and the expression profile of the transgene were evaluated in 14 tumors induced by a single injection of ethylnitrosourea (ENU), with or without additional beta-estradiol 3-benzoate (EB) treatment. Although no codon 12 mutations were detected, changes in codon 61 were evident in all lung adenocarcinomas, skin squamous cell carcinomas and forestomach squamous cell carcinomas examined. The mRNA levels of the transgene in these lesions were also elevated 1.71- to 4.77-fold, 3.04- to 5.18-fold, and 3.00- to 5.67-fold, respectively, in comparison with those in the normal livers of rasH2 mice. The results obtained in this study suggest that mutations in codon 61 and amplification of the transgene play key roles in the carcinogenesis induced by ENU in rasH2 mice.
Key Words: Human prototype c-Ha-ras transgenic mouse • rasH2 mouse • ethylnitrosourea (ENU) • transgene • mutation • overexpression.
References
- Anderson D. (2001). Expression of ras (p21) protein in plasma from exposed workers and from patients with lung disease. Int J Hyg Environ Health 204: 55—60.
- Ando K., Saitoh A., Hino O., Takahashi R., Kimura M., Katsuki M. (1992). Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes. Cancer Res 52: 978—982.[Abstract/Free Full Text]
- Biankin AV, Kench JG, Morey AL, Lee CS, Biankin SA, Head DR, Hugh TB, Henshall SM, Sutherland RL (2001). Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Cancer Res 61: 8830—8837.[Abstract/Free Full Text]
- Coutinho CM, Bassini AS, Gutierrez LG, Butugan O., Kowalski LP, Brentani MM, Nagai MA (1999). Genetic alterations in Ki-ras and Ha-ras genes in juvenile nasopharyngeal angiofibromas and head and neck cancer. Sao Paulo Med J 117: 113—120.
- Gulezian D., Jacobson-Kram D., McCullough CB, Olson H., Recio L., Robinson D., Storer R., Tennant R., Ward JM, Neumann DA (2000). Use of transgenic animals for carcinogenicity testing: Considerations and implications for risk assessment. Toxicol Pathol 28: 482—499.[Abstract/Free Full Text]
- Hayashi S., Mori I., Nonoyama T., Mitsumori K. (1998). Point mutations of the c-Ha-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-Ha-ras gene. Toxicol Pathol 26: 556—561.[Abstract/Free Full Text]
- Koujitani T., Yasuhara K., Usui T., Nomura T., Onodera H., Takagi H., Hirose M., Mitsumori K. (2000). Lack of susceptibility of transgenic mice carrying the human c-Ha-ras proto-oncogene (rasH2 mice) to phenolphthalein in a 6-month carcinogenicity study. Cancer Lett 152: 211—216.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Liu ML, Von Lintig FC, Liyanage M., Shibata MA, Jorcyk CL, Ried T., Boss GR, Green JE (1998). Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice. Oncogene 18: 2403—2411.
- Maronpot RR, Mitsumori K., Mann P., Takaoka M., Yamamoto S., Usui T., Okamiya H., Nishikawa S., Nomura T. (2000). Interlaboratory comparison of the CB6F1-Tg rasH2 rapid carcinogenicity testing model. Toxicology 146: 149—159.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Maruyama C., Tomisawa M., Wakana S., Yamazaki H., Kijima H., Suemizu H., Ohnishi Y., Urano K., Hioki K., Usui T., Nakamura M., Tsuchida T., Mitsumori K., Nomura T., Tamaoki N., Ueyama Y. (2001). Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice. Oncol Rep 8: 233—237.[Web of Science][Medline]
[Order article via Infotrieve]
- Mitsumori K., Furukawa F., Sato M., Yoshimura H., Imazawa T., Nishikawa A., Takahashi M. (1994). Promoting effects of ethinyl estradiol on development of renal proliferative lesions induced by N-nitrosobis (2-oxopropyl)amine in female Syrian golden hamsters. J Cancer Res Clin Oncol 120: 131—136.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mitsumori K., Wakana S., Yamamoto S., Kodama Y., Yasuhara K., Nomura T., Hayashi Y., Maronpot RR (1997). Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors. Mol Carcinog 20: 298—307.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mitsumori K., Koizumi H., Nomura T., Yamamoto S. (1998). Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies. Toxicol Pathol 26: 520—531.[Abstract/Free Full Text]
- Mori I., Yasuhara K., Hayashi S., Nonoyama T., Nomura T., Mitsumori K. (2000). Carcinogen dose-dependent variation in the transgene mutation spectrum in urethane-induced lung tumors in transgenic mice carrying the human prototype c-Ha-ras gene. Cancer Lett 153: 199—209.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mori I., Hayashi S., Nonoyama T., Yasuhara K., Mitsumori K., Masegi T. (2000). Point mutations of the c-Ha-ras gene in spontaneous pulmonary tumors of transgenic mice carrying the human c-Ha-ras gene. J Toxicol Pathol 13: 165—172.[CrossRef]
- Ogasawara H., Tsutsumi M., Takeda K., Usui K., Kobayashi H., Murakami H., Takagi H., Kumagai T., Konishi Y. (2000). Utility of transgenic mice carrying human prototype c-Ha-ras gene for alternative carcinogenicity testing of chemicals-negative results with Methapyrilene hydrochloride. J Toxicol Pathol 13: 179—188.[CrossRef]
- Roy HK, Olusola BF, Clemens DL, Karolski WJ, Ratashak A., Lynch HT, Smyrk TC (2002). AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. Carcinogenesis 23: 201—205.[Abstract/Free Full Text]
- Saitoh A., Kimura M., Takahashi R., Yokoyama M., Nomura T., Izawa M., Sekiya T., Nishimura S., Katsuki M. (1990). Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 5: 1195—1200.[Web of Science][Medline]
[Order article via Infotrieve]
- Storer RD (2000). Current status and use of short/medium term models for carcinogenicity testing of pharmaceuticals—scientific perspective. Toxicol Lett 112—113: 557—566.[CrossRef]
- Solanas M., Escrich E. (1996). Ha-ras in normal and tumoral tissues: Structure, function and regulation. Rev Esp Fisiol 52: 173—192.[Medline]
[Order article via Infotrieve]
- Suemizu H., Muguruma K., Maruyama C., Tomisawa M., Kimura M., Hioki K., Shimozawa N., Ohnishi Y., Tamaoki N., Nomura T. (2002). Transgene stability and features of rasH2 mice as an animal model for short-term carcinogenicity testing. Molecul Carcinogenesis 34: 1—9.[CrossRef]
- Sun XF, Ekberg H., Zhang H., Carstensen JM, Nordenskjold B. (1998). Overexpression of ras is an independent prognostic factor in colorectal adenocarcinoma. APMIS 106: 657—664.[Web of Science][Medline]
[Order article via Infotrieve]
- Tamaoki N. (2001). The rasH2 transgenic mouse: Nature of the model and mechanistic studies on tumorigenesis. Toxicol Pathol 29(suppl): 81—89.[Abstract/Free Full Text]
- Toyosawa K., Okimoto K., Kobayashi I., Kijima K., Kikawa E., Kohchi M., Koujitani T., Tanaka K., Matsuoka N. (2001). Di(2-ethylhexyl)phthalate induces hepatocellular adenoma in transgenic mice carrying a human prototype c-Ha-ras gene in a 26-week carcinogenicity study. Toxicol Pathol 29: 458—466.[Abstract/Free Full Text]
- Vickers AE, Lucier GW (1991). Estrogen receptor, epidermal growth factor receptor and cellular ploidy in elutriated subpopulations of hepatocytes during liver tumor promotion by 17 alpha-ethinylestradiol in rats. Carcinogenesis 12: 391—399.[Abstract/Free Full Text]
- Yamamoto S., Mitsumori K., Kodama Y., Matsunuma N., Manabe S., Okamiya H., Suzuki H., Fukuda T., Sakamaki Y., Sunaga M., Nomura G., Hioki K., Wakana S., Nomura T., Hayashi Y. (1996). Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice. Carcinogenesis 17: 2455—2461.[Abstract/Free Full Text]
- Yamamoto S., Hayashi Y., Mitsumori K., Nomura T. (1997). Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene. Lab Anim Sci 47: 121—126.[Web of Science][Medline]
[Order article via Infotrieve]
- Yamamoto S., Urano K., Koizumi H., Wakana S., Hioki K., Mitsumori K., Kurokawa Y., Hayashi Y., Nomura T. (1998). Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ Health Perspect 106(suppl. 1): 57—69.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Yamamoto S., Urano K., Nomura T. (1998). Validation of transgenic mice harboring the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Toxicol Lett 102—103: 473—478.[CrossRef][Web of Science]
Toxicologic Pathology, Vol. 31, No. 5,
491-495 (2003)
DOI: 10.1080/01926230390224683
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Okamura, M. Moto, M. Muguruma, T. Ito, M. Jin, Y. Kashida, and K. Mitsumori
A 26-Week Carcinogenicity Study of 2-Amino-3-Methylimidazo[4,5-f]Quinoline in rasH2 Mice
Toxicol Pathol,
February 1, 2006;
34(2):
199 - 205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
